Pharmaron Beijing Co., Ltd. (HKG:3759)

Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
21.66
-0.02 (-0.09%)
Dec 5, 2025, 4:09 PM HKT
57.41%
Market Cap 53.87B
Revenue (ttm) 14.80B
Net Income (ttm) 1.65B
Shares Out n/a
EPS (ttm) 0.94
PE Ratio 32.59
Forward PE 23.22
Dividend 0.22 (1.01%)
Ex-Dividend Date Jul 4, 2025
Volume 1,946,095
Average Volume 4,037,901
Open 21.86
Previous Close 21.68
Day's Range 21.30 - 21.86
52-Week Range 10.46 - 30.12
Beta 1.14
RSI 41.15
Earnings Date Mar 26, 2026

About Pharmaron Beijing

Pharmaron Beijing Co., Ltd., together with its subsidiaries, operates as a pharmaceutical research and development service platform in North America, Europe, the Mainland China, Asia, and internationally. It operates through five segments: Laboratory Services; Chemical and Formulation Process Development and Production Services; Clinical Research Services; Macromolecule and Cell and Gene Therapy Services; and Others. The company offers laboratory chemistry and biological science services, including small molecule chemical drugs, oligonucleotide... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2004
Employees 21,370
Stock Exchange Hong Kong Stock Exchange
Ticker Symbol 3759
Full Company Profile

Financial Performance

In 2024, Pharmaron Beijing's revenue was 12.28 billion, an increase of 6.39% compared to the previous year's 11.54 billion. Earnings were 1.79 billion, an increase of 12.01%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.